Aequus Pharmaceuticals Inc (AQS):企業の財務・戦略的SWOT分析

◆英語タイトル:Aequus Pharmaceuticals Inc (AQS) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH498090FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥68,400見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥102,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Aequus Pharmaceuticals Inc (Aequus Pharmaceuticals) is a drug discovery and development company that develops differentiated drugs. The company’s pipeline products include AQS304 finds application in the treatment of neurological disorders, and AQS303 is used for the treatment of treatment of vomiting of pregnancy and nausea. Aequus Pharmaceuticals markets pharmaceutical products such as Vistitan an ophthalmic solution that reduces elevated IOP in patients with ocular hypertension or open angle glaucoma; and Tacrolimus IR finds application in the prevention of acute rejection following solid organ transplantation. The company offers pharmaceutical products in therapeutic areas such as ophthalmology, neurology, and transplant. Aequus Pharmaceuticals is headquartered in Vancouver, British Columbia, Canada.

Aequus Pharmaceuticals Inc Key Recent Developments

Apr 07,2021: Apr 06, 2021 Aequus Provides update on Warrant Acceleration
Mar 01,2021: Aequus launches evolve eyedrops to eye care professionals in Canada
Feb 26,2021: Aequus Closes $1 Million Financing
Feb 17,2021: Aequus announces Marc Lustig joining board of directors and making direct equity investment

This comprehensive SWOT profile of Aequus Pharmaceuticals Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Aequus Pharmaceuticals Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Aequus Pharmaceuticals Inc – Key Information
Aequus Pharmaceuticals Inc – Overview
Aequus Pharmaceuticals Inc – Key Employees
Aequus Pharmaceuticals Inc – Key Employee Biographies
Aequus Pharmaceuticals Inc – Key Operational Heads
Aequus Pharmaceuticals Inc – Major Products and Services
Aequus Pharmaceuticals Inc – History
Aequus Pharmaceuticals Inc – Company Statement
Aequus Pharmaceuticals Inc – Locations And Subsidiaries
Aequus Pharmaceuticals Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Aequus Pharmaceuticals Inc – Business Description
Aequus Pharmaceuticals Inc – Corporate Strategy
Aequus Pharmaceuticals Inc – SWOT Analysis
SWOT Analysis – Overview
Aequus Pharmaceuticals Inc – Strengths
Aequus Pharmaceuticals Inc – Weaknesses
Aequus Pharmaceuticals Inc – Opportunities
Aequus Pharmaceuticals Inc – Threats
Aequus Pharmaceuticals Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Aequus Pharmaceuticals Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Aequus Pharmaceuticals Inc, Key Information
Aequus Pharmaceuticals Inc, Key Ratios
Aequus Pharmaceuticals Inc, Share Data
Aequus Pharmaceuticals Inc, Major Products and Services
Aequus Pharmaceuticals Inc, History
Aequus Pharmaceuticals Inc, Key Employees
Aequus Pharmaceuticals Inc, Key Employee Biographies
Aequus Pharmaceuticals Inc, Key Operational Heads
Aequus Pharmaceuticals Inc, Other Locations
Aequus Pharmaceuticals Inc, Subsidiaries
Aequus Pharmaceuticals Inc, Key Competitors
Aequus Pharmaceuticals Inc, SWOT Analysis
Aequus Pharmaceuticals Inc, Ratios based on current share price
Aequus Pharmaceuticals Inc, Annual Ratios
Aequus Pharmaceuticals Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Aequus Pharmaceuticals Inc (AQS):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • JM Financial Private Wealth Group:企業の戦略・SWOT・財務情報
    JM Financial Private Wealth Group - Strategy, SWOT and Corporate Finance Report Summary JM Financial Private Wealth Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Ontario Power Generation Inc:企業の戦略的SWOT分析
    Ontario Power Generation Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Microsoft Corporation (MSFT):企業の財務・戦略的SWOT分析
    Microsoft Corporation (MSFT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • BorgWarner Inc.:企業の戦略・SWOT・財務情報
    BorgWarner Inc. - Strategy, SWOT and Corporate Finance Report Summary BorgWarner Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Svelte Medical Systems Inc:医療機器:M&Aディール及び事業提携情報
    Summary Svelte Medical Systems Inc (Svelte) is a medical device company that manufactures and designs balloon expandable stents. The company offers products such as balloon expandable stents, svelte acrobat, and drug eluting stents, among others. Its svelte acrobat is a stent-on-a-wire bare metal co …
  • Leadiant Biosciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Leadiant Biosciences Inc (Leadiant Biosciences), formerly Sigma-Tau Pharmaceuticals Inc, a subsidiary of Leadiant Biosciences SpA, is a pharmaceutical company that discovers and develops novel medicines. The company provides products such as abelcet, adagen, carnitor, cystaran, depocyt, matu …
  • Sharps Compliance Corp (SMED):企業の財務・戦略的SWOT分析
    Summary Sharps Compliance Corp (Sharps) is a healthcare waste solution company that offers regulatory compliant services. The company offers products such as sharps disposal systems, public sharps safety, takeaway medication recovery system, collection and disposal system, complete needle collection …
  • Ajinomoto Co., Inc.:企業の戦略・SWOT・財務分析
    Ajinomoto Co., Inc. - Strategy, SWOT and Corporate Finance Report Summary Ajinomoto Co., Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Galmed Pharmaceuticals Ltd (GLMD):製薬・医療:M&Aディール及び事業提携情報
    Summary Galmed Pharmaceuticals Ltd (Galmed Pharmaceuticals), a subsidiary of Galmed International Ltd, is a clinical-stage biopharmaceutical company. The company focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, an oral therapy, which is in ARREST …
  • Delticom AG:企業の戦略・SWOT・財務情報
    Delticom AG - Strategy, SWOT and Corporate Finance Report Summary Delticom AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Inter Parfums SA:企業の戦略・SWOT・財務情報
    Inter Parfums SA - Strategy, SWOT and Corporate Finance Report Summary Inter Parfums SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • NeoGenomics Inc (NEO):企業の財務・戦略的SWOT分析
    Summary NeoGenomics Inc (NeoGenomics) is a cancer diagnostics and pharma services company that offers diagnostic, prognostic and predictive testing services. The company offers testing services with various technologies such as cytogenetics, fluorescence in-situ hybridization, flow cytometry, immuno …
  • Exillon Energy Plc (EXI):石油・ガス:M&Aディール及び事業提携情報
    Summary Exillon Energy Plc (Exillon) is an oil exploration and production company. The company explores, produces and develops crude oil. Its services include drilling, exploration, appraisal, development, operations, management, and production services. Exillon’s operating assets are located in two …
  • Banco Santander (Brasil) SA:企業の戦略・SWOT・財務情報
    Banco Santander (Brasil) SA - Strategy, SWOT and Corporate Finance Report Summary Banco Santander (Brasil) SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Enphase Energy, Inc. (ENPH):電力:M&Aディール及び事業提携情報
    Summary Enphase Energy, Inc. (EEI), formerly PVI Solutions, Inc., is an energy management solutions provider that designs, develops, manufactures and sells microinverter system. Its semiconductor-based microinverter system converts direct current (DC) electricity to alternating current (AC) electric …
  • AVI Limited:企業の戦略・SWOT・財務情報
    AVI Limited - Strategy, SWOT and Corporate Finance Report Summary AVI Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • BASF India Ltd (BASF):企業の財務・戦略的SWOT分析
    Summary BASF India Ltd (BASF) a subsidiary of BASF SE is a chemical company that manufactures and distributes specialty chemicals, performance products, plastics and crop protection products. The company’s chemical products include intermediates, monomers and petrochemicals. Its performance products …
  • Aramex (ARMX):企業の財務・戦略的SWOT分析
    Summary Aramex, formerly Arab International Logistics (Aramex) Co PJSC is a transport and logistics service provider that offers supply chain solutions. The company offers solutions such as e-commerce, logistics, small business solutions, developers solutions center, drop and ship, shop and ship, am …
  • Cypark Resources Berhad (CYPARK):企業の財務・戦略的SWOT分析
    Summary Cypark Resources Berhad (CRB) is a clean technology company that offers environmental engineering services. The company offers engineering and technology services on transforming dump sites to an economic and environmental boon. Its services include environmental remediation, integrated wast …
  • California Water Service Group (CWT):企業の財務・戦略的SWOT分析
    Summary California Water Service Group (California Water Service) is a utility service provider that offers wastewater services and water operation and maintenance services. The utility provides services such as water and wastewater utility services, and operating water and wastewater systems servic …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆